Kathryn S Torok

Summary

Affiliation: Children's Hospital of Pittsburgh
Country: USA

Publications

  1. pmc Coronary artery involvement in pediatric Takayasu's arteritis: Case report and literature review
    Shaun Mohan
    Division of Pediatric Rheumatology, Children s Hospital of Pittsburgh of UPMC, 4401 Penn Avenue, 15224, Pittsburgh, PA, USA
    Pediatr Rheumatol Online J 11:4. 2013
  2. pmc Pediatric scleroderma: systemic or localized forms
    Kathryn S Torok
    Division of Rheumatology, Children s Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, PA 15224, USA
    Pediatr Clin North Am 59:381-405. 2012
  3. pmc Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study
    Kathryn S Torok
    Division of Rheumatology, Children s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15224, USA
    J Rheumatol 39:286-94. 2012
  4. pmc Improvement in medication education in a pediatric subspecialty practice
    Aarat M Patel
    Division of Rheumatology and Clinical Immunology, University of Pittsburgh, S700 BST, 3500 Terrace Street, Pittsburgh, PA 15261, USA
    Pediatr Rheumatol Online J 8:25. 2010
  5. pmc Autoimmune thyroiditis in antinuclear antibody positive children without rheumatologic disease
    Kathryn S Torok
    University of Pittsburgh, Children s Hospital of Pittsburgh, Department of Pediatrics, Division of Rheumatology, Pittsburgh, Pennsylvania, USA
    Pediatr Rheumatol Online J 8:15. 2010
  6. pmc Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study
    Thaschawee Arkachaisri
    Department of Pediatrics, Division of Rheumatology, Children s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Rheumatology (Oxford) 49:373-81. 2010
  7. pmc Cytokine profiles in localized scleroderma and relationship to clinical features
    Katherine Kurzinski
    Division of Rheumatology, Children s Hospital of Pittsburgh of the University of Pittsburgh Medical Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15224, USA
    Cytokine 55:157-64. 2011
  8. pmc Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis
    Kathryn S Torok
    Children s Hospital of Pittsburgh, Department of Pediatrics, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, USA
    Clin Exp Rheumatol 28:S28-36. 2010
  9. pmc The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures
    Thaschawee Arkachaisri
    Division of Rheumatology, Children s Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    J Rheumatol 36:2819-29. 2009

Collaborators

Detail Information

Publications9

  1. pmc Coronary artery involvement in pediatric Takayasu's arteritis: Case report and literature review
    Shaun Mohan
    Division of Pediatric Rheumatology, Children s Hospital of Pittsburgh of UPMC, 4401 Penn Avenue, 15224, Pittsburgh, PA, USA
    Pediatr Rheumatol Online J 11:4. 2013
    ..We present a case of a pediatric patient with TA who had no symptoms of angina but who was found to have significant coronary artery involvement on diagnostic imaging. This necessitated tailoring of traditional management...
  2. pmc Pediatric scleroderma: systemic or localized forms
    Kathryn S Torok
    Division of Rheumatology, Children s Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, PA 15224, USA
    Pediatr Clin North Am 59:381-405. 2012
    ..Treatment of both forms targets the active inflammatory stage and halts disease progression; however, progress needs to be made toward the development of more effective antifibrotic therapy to help reverse disease damage...
  3. pmc Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study
    Kathryn S Torok
    Division of Rheumatology, Children s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15224, USA
    J Rheumatol 39:286-94. 2012
    ..To evaluate the effectiveness of a uniform single-center treatment protocol composed of high-dose methotrexate (MTX) and oral corticosteroids in a pediatric localized scleroderma (LS) cohort...
  4. pmc Improvement in medication education in a pediatric subspecialty practice
    Aarat M Patel
    Division of Rheumatology and Clinical Immunology, University of Pittsburgh, S700 BST, 3500 Terrace Street, Pittsburgh, PA 15261, USA
    Pediatr Rheumatol Online J 8:25. 2010
    ..The purpose of this study was to measure the impact of an educational intervention on parents of children taking methotrexate (MTX) for juvenile idiopathic arthritis (JIA)...
  5. pmc Autoimmune thyroiditis in antinuclear antibody positive children without rheumatologic disease
    Kathryn S Torok
    University of Pittsburgh, Children s Hospital of Pittsburgh, Department of Pediatrics, Division of Rheumatology, Pittsburgh, Pennsylvania, USA
    Pediatr Rheumatol Online J 8:15. 2010
    ..The purpose of the present study was to determine the frequency of thyroid antibodies in children referred to a pediatric rheumatology center for a positive ANA without evidence of a connective tissue disease...
  6. pmc Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study
    Thaschawee Arkachaisri
    Department of Pediatrics, Division of Rheumatology, Children s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Rheumatology (Oxford) 49:373-81. 2010
    ..To develop and assess the psychometric properties of the Localized Scleroderma (LS) Skin Damage Index (LoSDI) and Physician Global Assessment of disease Damage (PGA-D)...
  7. pmc Cytokine profiles in localized scleroderma and relationship to clinical features
    Katherine Kurzinski
    Division of Rheumatology, Children s Hospital of Pittsburgh of the University of Pittsburgh Medical Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15224, USA
    Cytokine 55:157-64. 2011
    ..This provides the platform to launch further investigations into the role of select cytokines in the pathogenesis of LS and to provide directed therapeutic options in the future...
  8. pmc Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis
    Kathryn S Torok
    Children s Hospital of Pittsburgh, Department of Pediatrics, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, USA
    Clin Exp Rheumatol 28:S28-36. 2010
    ....
  9. pmc The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures
    Thaschawee Arkachaisri
    Division of Rheumatology, Children s Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    J Rheumatol 36:2819-29. 2009
    ..To develop and evaluate a Localized Scleroderma (LS) Skin Severity Index (LoSSI) and global assessments' clinimetric property and effect on quality of life (QOL)...